HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kanako Hosono Selected Research

Prostaglandin-E Synthases

1/2016Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice.
12/2015Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model.
4/2011Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice.
11/2010Role of microsomal prostaglandin E synthase-1 in the facilitation of angiogenesis and the healing of gastric ulcers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kanako Hosono Research Topics

Disease

10Neoplasms (Cancer)
04/2024 - 09/2008
9Wounds and Injuries (Trauma)
01/2023 - 07/2008
5Endometriosis
10/2023 - 02/2011
5Inflammation (Inflammations)
10/2023 - 05/2011
5Ulcer
10/2014 - 01/2008
4Stomach Ulcer (Gastric Ulcer)
03/2014 - 01/2008
3Ischemia
11/2022 - 02/2011
3Ureteral Obstruction
01/2019 - 03/2015
3Fibrosis (Cirrhosis)
01/2019 - 03/2015
2Lymphedema (Milroy Disease)
10/2023 - 09/2011
2Reperfusion Injury
01/2023 - 08/2013
1Colorectal Neoplasms (Colorectal Cancer)
04/2024
1Body Weight (Weight, Body)
01/2024
1Obesity
01/2024
1Edema (Dropsy)
10/2023
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
07/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2021
1Nervous System Diseases (Neurological Disorders)
01/2019
1Migraine Disorders (Migraine)
01/2019
1Peritonitis
12/2015
1Diabetes Mellitus
10/2014
1Neoplasm Metastasis (Metastasis)
02/2014
1Lymphatic Metastasis
02/2014
1Lung Neoplasms (Lung Cancer)
02/2014
1Lewis Lung Carcinoma
02/2014
1Necrosis
02/2012
1Amniotic Fluid Embolism
08/2011
1Pain (Aches)
04/2011
1Bone Neoplasms (Bone Cancer)
04/2011
1Hemorrhage
03/2011

Drug/Important Bio-Agent (IBA)

15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2024 - 07/2008
7ProstaglandinsIBA
04/2024 - 02/2010
6Vascular Endothelial Growth Factor CIBA
01/2024 - 02/2010
5Dinoprostone (PGE2)FDA Link
10/2023 - 03/2010
5Calcitonin Gene-Related PeptideIBA
01/2020 - 01/2008
5Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2014 - 03/2010
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2012 - 11/2010
4Prostaglandin-E SynthasesIBA
01/2016 - 11/2010
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2015 - 02/2010
4Celecoxib (Celebrex)FDA Link
03/2015 - 02/2010
4Messenger RNA (mRNA)IBA
03/2014 - 02/2010
4Acetic Acid (Vinegar)FDA LinkGeneric
03/2014 - 01/2008
3CytokinesIBA
10/2023 - 03/2015
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2020 - 05/2011
3Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
01/2019 - 08/2013
3Prostaglandins EIBA
09/2011 - 02/2010
2ThromboxanesIBA
10/2023 - 02/2012
2Arachidonic Acid (Vitamin F)IBA
10/2023 - 10/2023
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
08/2020 - 03/2014
2Vascular Endothelial Growth Factor DIBA
01/2016 - 05/2011
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2015 - 05/2011
2Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
10/2014 - 07/2010
2Neutralizing AntibodiesIBA
03/2014 - 02/2009
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
03/2014 - 02/2010
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2014 - 09/2013
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2014 - 09/2013
2matrigelIBA
02/2014 - 05/2011
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2011 - 11/2010
2calcitonin gene-related peptide (8-37)IBA
02/2011 - 07/2008
1Triglycerides (Triacylglycerol)IBA
01/2024
1CholesterolIBA
01/2024
1Dietary Fats (Dietary Fat)IBA
01/2024
1Glucose (Dextrose)FDA LinkGeneric
01/2024
1Thromboxane A2 (A2, Thromboxane)IBA
10/2023
1MonocrotalineIBA
07/2021
1Phosphotransferases (Kinase)IBA
06/2021
1Receptor Activity-Modifying Protein 1IBA
10/2020
1Receptor Activity-Modifying ProteinsIBA
01/2020
1Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2019
1erenumabIBA
01/2019
1AntibodiesIBA
01/2019
1fremanezumabIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Mannose ReceptorIBA
01/2016
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2015
1Polyurethanes (Polyurethane)IBA
10/2014
1CXC ChemokinesIBA
03/2014
1Epidermal Growth Factor (EGF)IBA
03/2014
1Green Fluorescent ProteinsIBA
02/2014
1SolutionsIBA
02/2014
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2013
1Leukotriene B4IBA
08/2013
1Interleukin-6 (Interleukin 6)IBA
02/2012
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
02/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2012
1pro-calcitonin gene-related peptideIBA
04/2011
1Acetaminophen (Paracetamol)FDA LinkGeneric
03/2011
1Proteins (Proteins, Gene)FDA Link
02/2011
1Connective Tissue Growth FactorIBA
11/2010
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2010
1ChemokinesIBA
03/2010
1Prostaglandin Receptors (Prostaglandin Receptor)IBA
05/2009
1AngiotensinsIBA
02/2009

Therapy/Procedure

2Intraperitoneal Injections
11/2022 - 12/2015
1Transplantation
01/2023
1Oral Administration
02/2014
1Resuscitation
08/2011
1Subcutaneous Infusions
02/2011
1Subcutaneous Injections
02/2010
1Therapeutics
02/2009